Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Coyne

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Kidney International|April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextranBeckie Michael, Daniel W Coyne, Steven Fishbane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
The spectrum of infection-related morbidity in hospitalized haemodialysis patientsMichael Allon, Milena Radeva, James Bailey, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO StudyMichael Allon, Thomas A Depner, Milena Radeva, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Clinical Nephrology|April 10, 2008
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidismH H Malluche, M-C Monier-Faugere, G Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 2, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority TrialDaniel W Coyne, Ajay K Singh, Renato D Lopes, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Kidney International Reports|March 18, 2021
Roxadustat for CKD-related Anemia in Non-dialysis PatientsDaniel W Coyne, Simon D Roger, Sug Kyun Shin, et al.
The New England Journal of Medicine|April 9, 2004
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysisGeoffrey A Block, Kevin J Martin, Angel L M de Francisco, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Kidney International|April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextranBeckie Michael, Daniel W Coyne, Steven Fishbane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
The spectrum of infection-related morbidity in hospitalized haemodialysis patientsMichael Allon, Milena Radeva, James Bailey, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO StudyMichael Allon, Thomas A Depner, Milena Radeva, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Clinical Nephrology|April 10, 2008
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidismH H Malluche, M-C Monier-Faugere, G Wang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 2, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority TrialDaniel W Coyne, Ajay K Singh, Renato D Lopes, et al.
Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.
Kidney International Reports|March 18, 2021
Roxadustat for CKD-related Anemia in Non-dialysis PatientsDaniel W Coyne, Simon D Roger, Sug Kyun Shin, et al.
The New England Journal of Medicine|April 9, 2004
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysisGeoffrey A Block, Kevin J Martin, Angel L M de Francisco, et al.
Pageof 10